NCT03236064View on ClinicalTrials.gov

Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury

PHASE1UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Injury of Other Nerves at Wrist and Hand Level of Unspecified Arm, Initial Encounter
Interventions
DRUG

Polyethylene Glycols

Demonstrate more rapid and increased return of function by PEG-fusion compared to best current nerve repair techniques

Trial Locations (1)

17405

RECRUITING

WellSpanYork Hospital, York

Sponsors
All Listed Sponsors
collaborator

Neuraptive Therapeutics Inc.

INDUSTRY

lead

WellSpan Health

OTHER

NCT03236064 - Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury | Biotech Hunter | Biotech Hunter